Oncopeptides AB (publ) (ONCO.ST)
ONCO.ST Stock Price Chart
Explore Oncopeptides AB (publ) interactive price chart. Choose custom timeframes to analyze ONCO.ST price movements and trends.
ONCO.ST Company Profile
Discover essential business fundamentals and corporate details for Oncopeptides AB (publ) (ONCO.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Feb 2017
Employees
80.00
Website
https://www.oncopeptides.com/svCEO
Sofia Heigis
Description
Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.
ONCO.ST Financial Timeline
Browse a chronological timeline of Oncopeptides AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 19 Feb 2026
Upcoming earnings on 5 Nov 2025
Earnings released on 21 Aug 2025
Earnings released on 15 May 2025
EPS came in at -kr 0.29 , while revenue for the quarter reached kr 13.27M , missing expectations by -26.29%.
Earnings released on 27 Feb 2025
EPS came in at -kr 0.39 , while revenue for the quarter reached kr 9.91M , missing expectations by -17.38%.
Earnings released on 7 Nov 2024
EPS came in at -kr 0.29 , while revenue for the quarter reached kr 8.51M , missing expectations by -39.24%.
Earnings released on 14 Aug 2024
EPS came in at -kr 0.48 , while revenue for the quarter reached kr 8.16M , beating expectations by +16.50%.
Earnings released on 30 May 2024
EPS came in at -kr 0.53 , while revenue for the quarter reached kr 5.07M .
Stock split effective on 16 Apr 2024
Shares were split 1403 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 27 Feb 2024
EPS came in at -kr 0.90 falling short of the estimated -kr 0.70 by -28.87%, while revenue for the quarter reached kr 5.34M , beating expectations by +853.04%.
Earnings released on 8 Nov 2023
EPS came in at -kr 0.45 surpassing the estimated -kr 0.68 by +34.47%, while revenue for the quarter reached kr 2.81M , beating expectations by +400.89%.
Earnings released on 10 Aug 2023
EPS came in at -kr 0.62 surpassing the estimated -kr 0.68 by +7.92%, while revenue for the quarter reached kr 25.95M , beating expectations by +4.53K%.
Earnings released on 4 May 2023
EPS came in at -kr 0.79 falling short of the estimated -kr 0.66 by -18.59%, while revenue for the quarter reached kr 1.12M , beating expectations by +100.71%.
Earnings released on 16 Feb 2023
EPS came in at -kr 1.01 falling short of the estimated -kr 0.58 by -74.64%, while revenue for the quarter reached kr 560.00K , missing expectations by -97.29%.
Earnings released on 9 Nov 2022
EPS came in at -kr 1.00 falling short of the estimated -kr 0.72 by -38.89%, while revenue for the quarter reached -kr 958.00K , missing expectations by -147.90%.
Earnings released on 11 Aug 2022
EPS came in at -kr 0.79 surpassing the estimated -kr 0.87 by +9.20%, while revenue for the quarter reached kr 8.75M .
Earnings released on 4 May 2022
EPS came in at -kr 1.31 surpassing the estimated -kr 2.15 by +39.07%.
Earnings released on 17 Feb 2022
EPS came in at -kr 5.23 falling short of the estimated -kr 3.10 by -68.71%, while revenue for the quarter reached -kr 21.71M , missing expectations by -206.99%.
Earnings released on 24 Nov 2021
EPS came in at -kr 10.33 falling short of the estimated -kr 4.49 by -130.07%, while revenue for the quarter reached kr 54.28M .
Earnings released on 19 Aug 2021
EPS came in at -kr 0.32 surpassing the estimated -kr 4.85 by +93.40%, while revenue for the quarter reached kr 66.37M .
Earnings released on 26 May 2021
EPS came in at -kr 3.45 surpassing the estimated -kr 6.62 by +47.89%, while revenue for the quarter reached kr 19.36M .
Earnings released on 18 Feb 2021
EPS came in at -kr 7.59 falling short of the estimated -kr 6.22 by -22.03%.
Earnings released on 19 Nov 2020
EPS came in at -kr 5.71 surpassing the estimated -kr 6.06 by +5.78%.
ONCO.ST Stock Performance
Access detailed ONCO.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.